School of Cancer Sciences

An Integrated Cancer Research Strategy for Glasgow

‌Here, newly appointed Institute of Cancer Sciences Director, Professor Owen Sansom describes his vision for the strategy of the Institute over the next 5 to 10 years.

The ICS is one of the most highly regarded cancer research institutes in the UK, and Glasgow currently leads the world in key aspects of cancer biology. In the last 5 to 10 years, scientists at the ICS have made fundamental discoveries and developed new approaches that have changed the way in which we view cancer, and these offer the potential to revolutionise how we treat the disease. However, development of new therapies for cancer requires coordination of drug discovery with the strongest possible basic science and clinical programmes, and a proper balance of these components to ensure that effective new treatments are targeted to the most appropriate patients and accurately evaluated as they are translated into the clinic. This is key to our integrated cancer research strategy for Glasgow.
With its extremely strong track record in cancer biology and pre-clinical modelling, and access to a large patient base and clinical research infrastructure and expertise, the ICS has all the components to lead the translation of cancer research nationally and globally. Our aim is to integrate these components into a common cancer research strategy for Glasgow. To underpin our strategy, we are committed to leading a second-generation precision oncology agenda. This will extend patient stratification from one based on mutation (where we already lead in pancreatic cancer) to one which incorporates subtype, stroma metabolism and metastatic niche, and that will enable us to treat tumours more accurately by enriching for response, and help to drive a new ‘precision prevention’ agenda.

Components of Glasgow's Translation Pipeline

Connecting excellent discovery to clinical benefit in Glasgow

Within the ICS, we have research programmes that cover the spectrum of cancer research - from those that are very patient facing to those that address more basic research questions. Crucially, we have made significant contributions to understanding the processes that drive cancer progression and to practice-changing clinical research, whilst publishing at the highest levels. Moreover, this internationally recognised expertise and infrastructure gives us the ability to attract scientists and clinicians to Glasgow from all over the world. However, for Glasgow to reach its full potential in clinical translation, we need to increase the critical mass of our clinical academics and further support the ones that are already here.
The research environment that we have built around the themes of protein synthesis/cancer metabolism, metastasis/recurrence and precision oncology provide unique opportunities to build translational pipelines that connect basic science and drug discovery to the clinical trials capacity that we have in Glasgow. Our aim is to help provide direction to all of the researchers in these areas to ensure that they are working in teams with common goals, and to recruit new research leads in key areas with a particular emphasis on increasing our clinical strength.
The following objectives will be used to set our compass for this overarching aim, and to ensure that our basic science and clinical research programmes are properly coordinated and patient facing:

Key objectives for cancer research in Glasgow

• To find novel ways to treat cancer by targeting protein synthesis and energetic stress pathways;
• To reduce cancer recurrence by developing biomarkers for primed metastatic niches, and strategies to target metastatic organs;
• To build a cancer prevention agenda in Scotland starting with hepatocellular carcinoma and colorectal cancer.

We aim to lead on three tumour types in Glasgow (pancreas, colon and haematological malignancies) and have recently been awarded CRUK funding for the TASTER trial, an important stratified medicine trial for chronic myeloid leukaemia. We also have significant strength in other cancer types in the ICS: prostate, breast and brain cancers, and these have and will continue to benefit from Glasgow-wide expertise and infrastructure. In addition, we are a CRUK emerging centre of excellence for radiotherapy and hope to build capacity in this area.

A strategy to support delivery of Glasgow’s cancer research objectives

In order to facilitate the delivery of these important cancer research objectives in the next 6 to 12 months, we will be strengthening clinical academia in Glasgow; ensuring that the various components within Glasgow are working in close harmony; and making integrated funding applications to support our work. Initially, this will involve a drive to recruit and maximise support for both senior clinician scientists and early career clinical talent, along with a series of meetings to bring together teams of our scientists and clinicians in key areas - and I look forward to updating you on our progress with all of this in future newsletters.

Prof Anthony Chalmers – Scottish Radiotherapy Research Forum (ScoRRF)

Prof Anthony Chalmers: "I am delighted to announce that the 7th annual scientific meeting of the Scottish Radiotherapy Research Forum will be held on 1st November 2018 at the Stirling Court Hotel, University of Stirling".
 
The purpose of the meeting is to bring together researchers, clinicians, academics and students working in all aspects of radiotherapy to provide a platform for knowledge transfer and networking. This year's theme will be: Immuno-Radiotherapy; Combining Precision Drugs with Precision RT
 
We have put together an outstanding programme of international and national speakers on a variety of topics within this theme, and for the first time there will be four oral presentations selected from submitted abstracts.
 
For Registration:  http://www.gla.ac.uk/conferences/scorrf/  Just click on the link button on the Website.  Follow the link button if you wish to submit an abstract.
For Directions:  Getting there

The charge of £50 includes lunch and refreshments on the day.  Please book as early as possible to guarantee your space.
 
The meeting is mutli-disciplinary and will be of interest (and enjoyment!) to anybody working in clinical or research fields related to radiotherapy.
 
We look forward to seeing you in Stirling.

ScoRRF Flyer and ScoRRF Programme

Paul O'Gorman Leukaemia Research Centre News

Recent Fundraising

Charity Event: Inaugural POG Gin tasting at the Macintosh Church on the 27th September 2018 – This event held last month was sold out.

Future Fundraising Events

McGuigan Family Charity Night – Saturday 13 October, 7:00pm, St David’s Hall, Plains, Airdrie

Craft Fair – Saturday 27 October, West Kilbride

Waitrose Craft Fair –Sunday 4 November, 10-6pm

Christmas Craft Fair & Tearoom – Sunday 25 November, 2-5:00pm, Knightswood Community Centre.

For details and information about any of these events, please contact Mrs Susanne Hill, Development and Alumni Co-ordinator, Level 2, No 2 The Square, University of Glasgow
Email:  Susanne.hill@glasgow.ac.uk  Telephone – 0141 330 5092

Recently held talks at meetings

20th Annual John Goldman Conference on Chronic Myeloid Leukaemia Therapy and Biology, Sept 13-16 2018, Miami, USA

Dr Chinmay Munje, Post-doctoral researcher – “Combination of asciminib (ABL001) with ATP-competitive tyrosine kinase inhibitors targets early CML progenitor cells”

Dr Leena Mukherjee, Clinical Research Fellow and PhD student – “Rho kinase is a promising new target in CML”

Dr Ross Kinstrie, Post-doctoral researcher – “Targeting PRC2 activity as a novel therapeutic strategy in advanced phase CML”

Dr Alison Michie, Reader in Molecular Lymphopoiesis, presented a talk at the Lymphoma Action meeting in Glasgow on 8 September 2018 – “The challenges faced by drugs used to treat leukaemia and lymphoma”

Polyomics Symposium

REGISTRATION NOW OPEN! Scottish Metabolomics Network Symposium

The Scottish Metabolomics Network Symposium 2018 will take place on the following:

Date: Thursday 1st & Friday 2nd November 2018
Location: Discovery Point Exhibition Centre, Dundee

Registration:
Please register via the following URL https://tinyurl.com/SMN18
Registration Fees:
Standard Rate after Wednesday 19th September 2018: £60

Further information will be available at: http://scottishmetabolomics.net/events/
Follow the event on twitter using #ScotMetNet
Tweets using this hashtag will be displayed at: http://scottishmetabolomics.net/
Read about the latest SMN Newsletter at: http://scottishmetabolomics.net/newsletter/

PRECISION-Panc at Glasgow Science Festival

(report from Kirsteen Campbell, Research Engagement Manager, CRUK Glasgow Centre)

In June this year, the CRUK Glasgow Centre organised a city centre public event to talk about PRECISION-Panc as part of this year’s Glasgow Science Festival Programme.

CRUK Beatson Institute Director, Prof Owen Sansom hosted a series of lay talks which covered the pre-clinical, clinical and patient involvement aspects of the project. Prof Sansom provided an overview on personalised medicine and the cancer landscape across Glasgow. The audience then heard from Dr Stephan Dreyer, Dr Jen Morton and Prof Andrew Biankin. Janice Tannock, a patient involvement representative from Pancreatic Cancer UK recounted her experience of supporting her father through pancreatic cancer till his passing, reminding everyone why it’s essential this project is a game-changer.The need is clear.

After each talk the audience were invited to ask questions which were principally around how long it might take before patients would start to see a benefit, how patients could get involved, where to find further information and what challenges the NHS may face with a likely future boom of ‘the right medicine for the right person at the right time’.

Nurses from Cancer Research UK and Pancreatic Cancer UK hosted tables to chat to people about information and support for people with pancreatic cancer. The event was evaluated by Glasgow Science Festival and the feedback provided was exceptionally positive with the vast majority of the audience rating it as ‘excellent’.

With Glasgow leading PRECISION-Panc, this Glasgow Science Festival event provided a platform to showcase Glasgow’s key role in pancreatic cancer research, to hear from and question some of the senior figures involved in delivering the project and highlight the collaborative approach to tackling this disease.

Speaker Biographies Event Progamme Running Order

Prof Jeff Evans interviews with Touch Oncology and VJOncology

Prof Evans recently gave two interviews:

Interview with Touch Oncology can be accessed here Touch Oncology Prof Jeff Evans

Interview with VJOncology at the UK Oncology Forum meeting providing an update on pancreatic cancer.
 VJOncology Prof Jeff Evans, the rest of the Oncology Forum videos can be viewed here: VJOncology Event 2018

MOOC makes research impact a top priority

Professor Nicol Keith who leads this course, said: “Universities worldwide are committed to realising the economic and societal impact of their research. By developing this online course with direct input from a range of stakeholders, we hope to help people understand the research impact landscape and importantly to give them tools, tactics and confidence to really make a difference. The course is interactive and we are looking forward to some lively discussions.”

Research Impact: Making a Difference begins on 22 October 2018, for more details visit Future Learn

Read more about Research Impact: Making a Difference

Staff News

Stephen Tait

Congratulations to Stephen Tait who has been promoted to Professor
An Inaugural Lecture will be arranged for early 2019

A warm welcome to our new staff

‌

I am Judith Dixon-Hughes and have just started as Project Manager for the Precision Panc study working with Prof Biankin and the team at the Glasgow Precision Oncology Lab. I previously worked at the CRUK, Clinical Trials Unit, Glasgow based at the Beatson WoSCC and am looking forward to getting my teeth into my new role here at the Wolfson Wohl Cancer Research Centre. If anyone has any queries regarding the Precision Panc platform please do not hesitate to get in touch and I will do my best to help you. Contact: 0141 330 2718 Judith.dixon@glasgow.ac.uk

‌

I am Anna Morris and I have just joined the Glasgow Precision Oncology Lab (GPOL) team as a Project Manager. Previously I was a Project Manager at the CRUK Clinical Trials Unit Glasgow, and I have many years of experience managing early phase radiotherapy combination trials and randomised phase II drug trials, with a focus on glioblastoma and tumour biomarker studies. Contact: 0141 330 7282 Anna.Morris@glasgow.ac.uk

Thomas Drake will be starting as a clinical research fellow with Dr Tom Bird, a Wellcome Trust Intermediate Research Fellow in September and will be based in the CRUK Beatson Institute. Tom has two-year University Endowment funding and will be investigating some of the key molecular drivers of liver cancer with the goal of improving therapeutic options for patients.

Sidhartha Dongre has started work as a Technician in Professor Anthony Chalmers lab at the WWCRC. After studying Biomedical Science and Neuroscience at BSc level at the University of Sheffield, he then completed his PhD in the same department - studying visual circuit functions and flight behaviour in fruit flies. His new position focusses upon the DNA damage response and the use of pharmaceuticals to bolster radiotherapy.

Dr Gareth Inman has joined the Institute as Director of Research Strategy Institute of Cancer Sciences and is based in the CRUK Beatson Institute.

Natalia Brzozowska is a technician based on level 4 of the Wolfson Wolh Cancer Research Centre.

Lyle Simpson joins us as a Research Traineer Programmer at the Clinical Trials Unit.

Joining Dr Seth Coffelt's lab is Rhona Millar a Glasgow University 4th year undergraduate student. As part of the University's MSci program she had the opportunity to take a year out from her immunology degree and work in industry or research. She has always enjoyed learning about cancer immunology on her course and found Seth’s research and Nature paper extremely interesting. Rhona is looking forward to the upcoming year and what she will be able to learn in his lab. Email:2135232M@student.gla.ac.uk

New Radiation Supervisor for the Wolfson-Wohl Cancer Research Centre
Donna Nile has fulfilled the role of Radiation Supervisor for the Wolfson-Wohl Cancer Research Centre since November 2014.  However, she has now handed over the reins to the very capable Allan McVie.  Alan will continue to monitor the use of radiation within the WWCRC, and new radiation users should contact Allan in the first instance (Allan.McVie@glasgow.ac.uk)

Joana Bittencourt Silvestre, Bioinformatician at the Paul O’Gorman Leukaemia Research Centre (POG-LCR) will travel to Melbourne, Australia, in October, to visit Christine Wells' lab. There, she will expand the POG-LRC/ Wells lab collaboration initiated by Professor Tessa Holyoake on the leukaemia specific transcriptomics platform from Stemformatics, Leukomics. This visit has been jointly funded by the friends of the Paul O’Gorman fundraising and the Wells lab.

Congratulations to Dr Alison Laing, Clinical Research Fellow and PhD Student who gave birth to her second child, a healthy baby boy Joshua.  Both are doing well. 

Awards

Seth Coffelt group

Seth's group were awarded a project grant from Breast Cancer Now entitled “Regulation of IL-17-producing gamma delta T cells in breast cancer metastasis"

Dr Helen Wheadon, Senior Lecturer and Associate Dean Post Graduate Research was awarded the Senior Fellowship of Recognising Excellence in Teaching on 21 July 2018

Dr Alison Michie, Reader in Molecular Lymphopoiesis, has been awarded a Bloodwise Project Grant “Elucidating the mechanisms that regulate FOXO activity in CLL – a novel target for therapeutic exploitation?” with co-applicant Dr A. McCaig. Ref. (£249,000)

PhD Student News

‌Congratulations to Elodie Kuntz (PhD Student) who was awarded the Joseph Black Medal & Hird Prize for her PhD thesis 'An investigation of metabolic vulnerabilities in chronic myeloid leukaemic stem cells'

Sarah-Jane Remak (PhD Student, Seth Coffelt group) won best poster prize at the Gamma Delta T Cell Conference in Bordeaux in June 2018.

Congratulations to the following PhD students who recently passed their VIVA’s: Eirini Lampraki (Prof Andrew Biankin) , Selina Tsim (Prof Anthony Chalmers), Laura Richmond (Dr Adam West) and Alex Binks (Prof Iain McNeish).

Welcome to all of our new PGR students 2018/19

Bashir Mohamed (supervisor Jim Norman)
Aldo Bader (supervisor Jim Norman)
Michalis Gounis (supervisor Jim Norman)
Sarah Gillen (supervisor Martin Bushell)
Robert John Rulach (supervisor Anthony Chalmers)
Mariana Cendejas Orozco (supervisor David Vetrie)
Alexandrina Pancheva (supervisor Thomas Otto)
Tom Drake (supervisor Tom Bird)
Sarah Laing (supervisor Daniel Murphy)
Ahmed Khalaf (supervisor Vignir Helgason)
Shaun Patterson (supervisor Xu Huang)
Adiba Khan (supervisor Karen Blyth)
Andre Medina (supervisor Julia Cordero)
Andrew Hartley (supervisor Imran Ahmad)
Peter Walsh (supervisor Ania Wilczynska)
Rachel Harris (supervisor Gillian MacKay)
Curtis Rink (supervisor Jen Morton)
Hakem Albilasi (supervisor Karen Keeshan)
Maryam Barashdi (supervisor Karen Keeshan)
Sichen Li (supervisor Karen Keeshan)
Ayesha Iqbal (supervisor Helen Wheadon)

Welcome to our MSc Students 2018/19

Nina Murdoch from North Berwick, Scotland

"I chose Glasgow because the course sounded really good and interesting with amazing facilities as well as wanting to experience Glasgow. I know Edinburgh quite well but have never spent much time in Glasgow so I'm excited to get to know it!"

Antigoni Kokkinopliti from Greece

"I am from Katerini, a small town in Greece and I just moved to Glasgow. There are many reasons why I chose Glasgow for my studies. First and foremost, I had heard the best for the University of Glasgow and the fact that this Master Program is for one year helped me to take a decision.  The life costs played an important role, as Glasgow is cheaper than other cities in the UK. Finally, some pictures on the Internet showed that it will be an ideal place for me. Glasgow looks as wonderful as I expected it to be.
My program is called Cancer Sciences and it is related to cancer which is a very common disease in our days. By applying for this program, I was expecting to learn several information on what is cancer, how it is developed, how it can be prevented and how it can be treated. Although I need generic background knowledge, the research of treatment is what I would like to focus on. Regarding my future on this field, I can imagine myself working in a laboratory. However, before I decide my next step, I want to take advantage of this course and learn about all my opportunities such as being a PhD student or finding a job on different research fields".

Publications and publicity

Prof Andrew Biankin

The Scottish Genomes Partnership story made the front page, with an inside page full story and an accompanying separate piece relating to cystic fibrosis and reproductive counselling. Prof Andrew Biankin, Director of the Wolfson Wohl Cancer Research Centre and Co-Chair of the Scottish Genomes Partnership said: "Genomic testing allows us to start predicting which therapies will work best for an individual cancer patient, improving outcomes whilst minimising side-effects and costs".
Thanks to all of those who helped put the press release together, particularly Jen Middleton in the Edinburgh press office who led on the discussions with the Scotsman.

Prof Paul Shiels

"A molecular signature for delayed graft function"

Recent Aging Cell paper which also made The Times Prof Paul Shiels and The Scotsman Prof Paul Shiels

University of Glasgow news

Wiley online library

Daniel Murphy Group

"The ERBB network facilitates KRAS-driven lung tumorigenesis"

B Kruspig, T Monteverde, S Neidler, A Hock, E Kerr, C Nixon, W Clark,

Science Translational Medicine 10 (446), eaao2565

The paper received lots of media attention with articles in the Guardian and the Times and a video on the ITV news website.  
It was also highlighted by 2 editorials in Nature Reviews Cancer and Nature Reviews Clinical Oncology:
https://www.nature.com/articles/s41568-018-0044-1
https://www.nature.com/articles/s41571-018-0068-1

"Colorectal tumors require NUAK1 for protection from oxidative stress"

J Port, N Muthalagu, M Raja, F Ceteci, T Monteverde, B Kruspig, A Hedley
Cancer discovery 8 (5), 632-647

Dr Vignir Helgason Group

Baquero et al, “Second Generation Autophagy Inhibitors Promote Elimination of Quiescent Leukaemic Stem Cells”. (2018), Leukemia.

Angela Ianniciello, Kevin Rattigan and Vignir Helgason. “The ins and outs of metabolism and autophagy in hematopoietic and leukaemic stem cells: food for thought”. (2018), Frontiers in Cell and Developmental Biology.

Pablo Baquero, Amy Dawson, and Vignir Helgason. “Autophagy and Mitochondrial Metabolism: Insights into their Role and Therapeutic Potential in Chronic Myeloid Leukaemia”. (2018), The FEBS Journal (State of-the-Art Review)


Paul O'Gorman Leukaemia Research Centre Groups

"Chronic myeloid leukaemia cells require the bone morphogenic protein pathway for cell cycle progression and self-renewal"
Toofan P, Busch C, Morrison H, O'Brien S, Jørgensen H, Copland M, Wheadon H.  Cell Death Dis. 2018 Sep 11;9(9):927

"Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK"
Cross NCP, White HE, Evans PAS, Hancock J, Copland M, Milojkovic D, Mason J, Craine S, Mead AJ.  Br J Haematol. 2018 Sep;182(6):777-788

"Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis" 
Salomé M, Hopcroft L, Keeshan K.
Exp Hematol. 2018 Jul 20. pii: S0301-472X(18)30637-4

"The role of mTOR-mediated signals during haemopoiesis and lineage commitment"
Malik N, Sansom OJ, Michie AM.  Biochem Soc Trans. 2018 Aug 28

Targeting quiescent leukemic stem cells using second generation autophagy inhibitors.
Baquero P, Dawson A, Mukhopadhyay A, Kuntz EM, Mitchell R, Olivares O, Ianniciello A, Scott MT, Dunn K, Nicastri MC, Winkler JD, Michie AM, Ryan KM, Halsey C, Gottlieb E, Keaney EP, Murphy LO, Amaravadi RK, Holyoake TL, Helgason GV.  Leukemia. 2018 Sep 5

Prof Jeff Evans

"Study: efficacy and safety of Nivolumab and Nivolumab plus Ipilimumab in patients with metastatic esophagogastric cancer. Journal of Clinical Oncology" (in press).
Janjigian, Y.Y., Bendell, J., Calvo, E., Kim, J.W., Ascierto, P.A., Sharma, P., Ott, P.A., Peltola, K., Jaeger, D., Evans, T.R.J., de Braud, F., Chau, I., Harbison, C.T., Dorange, C., Tschaika, M., Le, D.T. CheckMate-032

"Somatic Cancer Genetics in the UK: Real-World Data from Phase One of the Cancer Research UK Stratified Medicine Programme" ESMO Open (in press).
Lindsay, C.R., Shaw, E., Blackhall, F., Blyth8, K.G., Brenton, J.D., Chaturvedi, A., Clarke, N., Dick, C., Evans, T.R.J., Hall, G., Hanby, A.M., Harrison, D.J., Johnston, S., Mason, M.D., Morton, D., Newton-Bishop, J., Nicholson,  A.G., Oien, K.A., Popat, S., Rassl, D., Sharpe, R., Taniere, P., Walker, I., Wallace, W.A., West, N.P, Butler, R., Gonzales de Castro, D., Griffiths, M., Johnson, P.W.M.

"Detection of Circulating Tumor Cell Clusters in Human Glioblastoma" British Journal of Cancer (in press).
Krol, I. Castro-Giner, F., Maurer, M., Gkountela, S., Szczerba, B., Scherrer, R., Coleman, N., Carreira, S., Bachmann, F., Anderson, S., Engelhardt, M., Lane, H., Evans, T.R.J., Plummer, R., Kristeleit, R., Lopez, J., Aceto, N.

"Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high grade serous ovarian and squamous non-small cell lung cancer" Annals Oncology (in press).
Basu, B., Krebs, M.G., Sundar, R., Wilson, R.H., Spicer, J., Jones, R.H., Brada, M., Talbot, D.C., Steele, N., Garces, A.H.I., Brugge, W., Harrington, K., Evans, T.R.J., Hall, E., Tovey, H., de Oliveira, F.M., Carreira S., Swales, K., Ruddle, R., Raynaud, F.I., Purchase, B., Dawes, J.C., Parmar, M., Turner, A.J., Tunariu, N., Banerjee, S., de Bono, J., Banerji, U.


Dr Torsten Stein

"Fibulin-2 is required for basement membrane integrity of mammary epithelium"
(Published 20th September 2018) Article

Dr Julia Cordero

Alessandro Scopelliti*, Christin Bauer*, Yachuan Yu, Tong Zhang, Björn Kruspig, Daniel J. Murphy, Marcos Vidal, Oliver D.K. Maddocks and Julia B. Cordero
"A neuronal relay mediates a nutrient responsive gut/fat body axis regulating energy homeostasis in adult Drosophila"
Journal: Cell Matabolism. Paper available here

Open Access Update

The new on demand reporting model ‘ClickView’ is still being rolled out for testing. It is hoped that named people within each College and School will receive training in October. For now, the Library will continue to email monthly snapshot ‘REF at risk’ reports in the current excel format.


If you have any queries, please contact the Open Access Team at research-openaccess@glasgow.ac.uk

Halloween Event

Come and join us for pizza and drinks Wednesday 31st October 12.30pm - 1.30pm

The ICS Social Committee are running quarterly seasonal events and if you are interested in joining the team you can contact us at:

cancersci-ins-newsletter@glasgow.ac.uk

International Men's Day Event

"Movember" (Prostate Cancer UK) we will be hosting an International Men's Day event on Monday 19th November

UoG Mental Health First Aid

The University of Glasgow, as part of its Mental Health Action Plan, undertook to develop a holistic, multi-stranded approach to employee and student mental health and wellbeing.

At ICS we have three local dedicated mental health first aiders but you may contact any of the Mental Health First Aiders listed on the network, and are not restricted to those within your local area. Please bear in mind that all the Mental Health First Aiders are volunteers, and have other roles, therefore your first choice may not always be available. In this case please do not give up, try other First Aiders on the list. They all want to help.

The Institute of Cancer Sciences contacts for the University’s new Mental Health First Aid initiative are:

Sharon Burns
Anne Best
Joanne Edwards

More details can be found here:

Mental Health First Aid

Network for Early Career Researcher Development (NERD) welcomes ICS

‌
The Network for Early Career Researcher Development (NERD) brings together early career researchers in the Institute of Cardiovascular and Medical Sciences (ICAMS) and the Institute of Infection, Immunity & Inflammation (IIIs); and now also includes the Institute of Cancer Sciences (ICS).

We have been warmly welcomed by the founding committee and would like to extend the invitation to you to join the celebrations marking the merger with our institute with a social event to be held on Friday 26th October at the tennis court social room on the Garscube Estate (3pm -5pm). There will be short welcoming talks and activities to involve the guests, pizzas and drinks for the occasion. Senior staffs are particularly welcomed to attend to show their support, to reinforce the Institute commitment to the NERD initiative and convey this opportunity to their teams.

Information about NERD and its remit, as well as useful information for all aspects of career development, including past and upcoming events and Athena SWAN initiatives can be found at the website https://www.gla.ac.uk/colleges/mvls/supportforresearch/nerd/.

NERD welcomes anyone in IIIs, ICAMS and ICS who identify themselves as Early Career Researchers (ECRs). Although our target audience is mainly postdoctoral researchers and research fellows (both clinical and non-clinical), technical staff, lecturers and PhD students are also able to attend events of specific interest.

It is important that this network fulfils the needs of NERD members, so please e-mail cams-iii-nerd-committee@lists.cent.gla.ac.uk with any comments or suggestions.
Check out the NERD resources available to help with planning your scientific career!

Don’t hesitate to get in touch if you have proposals for events and follow us on Twitter!

Hope to see you there!
ICS NERD committee

Chantevy Pou 

Alice Newman  

Grace McGregor

MVLS IMAGES WITH IMPACT 2018 Competition – Closing Date FRIDAY 2nd NOVEMBER 2018

 
The MVLS Images with Impact 2018 Competition will officially launched on 1st October 2018. This competition encourages staff and students to submit images, the winner being used as the front of the College Christmas Card 2018.

Images can show either the application of research, including public engagement activities OR showcase aspects of life within MVLS and the University to the wider world.

All details can be found at the competition website and included a promotional banner and promotional slide.